The condition women say ‘took my mother’s name out of her mouth’ — linked to Ditropan, handed to millions for a leaky bladder

Margaret Bowen stayed dry for twenty-two years.

She was 58 when a doctor first wrote her a prescription for Ditropan — oxybutynin, the drug handed to women all over the country for a leaky, overactive bladder. It worked. The accidents stopped. She took one every morning for the next two decades, and not one appointment in those twenty-two years mentioned her memory.

“Her bladder was beautifully controlled right to the end,” her daughter said. “By that end she looked me dead in the face and did not know my name.”

Oxybutynin belongs to a drug class called anticholinergics. They work by blocking acetylcholine — and acetylcholine is the exact brain chemical that Alzheimer’s disease destroys first.

Two large population studies have followed people taking anticholinergics for years and compared them against people the same age who never took them. Both found the same association: roughly three times the rate of dementia. Neither proves the drug caused it. Neither is mentioned at the pharmacy counter.

From a leaky bladder to twenty-two years on one pill

Overactive bladder affects an estimated 33 million American adults, and women are diagnosed with it far more often than men after menopause — the point at which oestrogen falls and the tissue it maintained begins to thin.

Margaret was first prescribed after mentioning, almost in passing, that she had started planning her days around where the bathrooms were.

She was started at 5 milligrams a day. Her doctor called it the standard of care, said she would likely be on it for life, and told her that was fine, because it would keep the accidents away.

“The accidents did stay away,” her daughter said. “Every single day, for twenty-two years. Everything else fell apart.”

Within the first year her mouth was so dry she kept a glass of water in every room. She started forgetting the small things. Her keys. A name. Whether she had eaten lunch.

“The doctor said it was just getting older,” her daughter said. “She was 59.”

What an anticholinergic actually blocks

Anticholinergics are among the most commonly prescribed drugs in older adults, appearing in treatments for overactive bladder, allergies, sleep, depression and Parkinson’s disease. Many are available without a prescription.

They work by blocking acetylcholine, a signalling chemical the body uses in two places at once: the smooth muscle of the bladder, and the pathways in the brain that handle attention and memory. A drug cannot block it in one place and leave it alone in the other.

By year three Margaret scored 24 out of 30 on the short memory test at her clinic. Her dose was moved from 5 milligrams to 10.

By year five she could not follow a recipe she had made a hundred times, and the test came back 19 out of 30.

“This was a woman who ran the church accounts in her head for thirty years and was never off by a penny,” her daughter said.

“Thirty-six years she mailed every grandchild a hand-written card on their birthday. That year she forgot all four.”

“Her bladder is beautifully controlled. The forgetfulness is just her age. A little memory slip past 70 is normal.” — what the family says they were told, repeatedly

Her daughter said the answer never changed, at any appointment, for years.

“She still did the Tuesday crossword in ink,” she said. “She still walked a mile every morning. Getting older was not the whole story.”

The prescribing label for oxybutynin carries warnings about confusion and memory in older adults. “Nobody read it to her,” her daughter said. “Nobody read it to me either.”

The pattern is not rare. Adults on anticholinergics for bladder symptoms often stay on them for a decade or more, and the drug class is rarely revisited once it is working.

What makes it hard to catch is that nothing announces itself. There is no bad week to point at. It arrives as a test score sliding from 24 to 19, in a woman whose chart looks immaculate.

“If the one thing you came in about is under control,” her daughter said, “nobody goes looking for what else changed.”

The gap between two specialists

Her daughter is 62, and had been taking the same drug herself for eleven years.

She found out the way most people do — reading, at night, on a phone.

“I saw a statistic that made me sick,” she said. “Three times. Not a little more likely. Not twice.”

What she could not get past was that she had been swallowing it every morning for eleven years, and had sat in a great many appointments, and had never once been told the finding existed.

“Your urologist treats your bladder,” she said. “Your regular doctor treats whatever else walks in the door that day. Nobody in that building has ever seen the whole medication list on one page except you.”

That is the part she wants other women to hear. Not that the drug is evil. That the list is nobody’s assignment.

She printed hers out — every tablet, on one page — and took it to the person who had prescribed most of it.

She did not ask whether she should stop. She asked what it was doing that nobody was watching.

“The conversation lasted nine minutes and changed the whole year.”

She was not told to stop. She was told her dose could come down, and that the bladder symptom underneath it had a cause nobody had ever explained to her.

That cause is not a mystery. After menopause, oestrogen falls, and an enzyme called 5-alpha-reductase gets a louder say, converting more testosterone into DHT.

DHT pushes on the follicle. It pushes on the bladder wall too. One shift, showing up in two places, treated by two different people who never see each other’s notes.

“That was the first time the thinning hair and the three-in-the-morning bathroom trip stopped being two separate complaints,” she said.

It took her the better part of a year to find anything aimed at that shift rather than at the symptom on top of it.

“I did not want another tablet added to a list I had just finished being frightened by.” — what the family says they were told, repeatedly

What she found was not a drug.

A valley in southern Austria

In Styria, in southern Austria, pumpkin seed oil is not a supplement aisle product. It is food, pressed locally, and it has been eaten there for generations.

It is also the subject of the one thing this story has that the rest of it does not: a controlled trial.

A 24-week randomised controlled trial of pumpkin seed oil, published in Evidence-Based Complementary and Alternative Medicine, measured roughly 40% more hair count than placebo. That trial was run in men. The DHT pathway is the bridge to female pattern thinning, and it is a bridge, not a substitute for a trial in women.

A separate 2014 trial, in the Journal of Traditional and Complementary Medicine, measured overactive-bladder symptom scores improving significantly at six weeks and again at twelve.

Two trials, two symptoms, one pathway — and a food-source oil rather than a drug that blocks a brain chemical.

She started taking it alongside everything else she was on. Nothing was stopped. Nothing was swapped.

“The first thing that changed was the count in the brush, somewhere around the second and third week. Not a transformation. A reduction.”

“Which surprised me,” she said, “until I remembered they run on the same pathway.”

By around the two-month mark the part in photographs had stopped moving.

Bone-dry days. Eight hours of unbroken sleep instead of four trips to the bathroom. A part that closed back up from four millimetres wide to two.

“Nobody is coming to read the list for you.” — Margaret Bowen’s daughter

What she wants other women to do

She is careful about what she is and is not saying, and repeats it more than once.

She is not telling anyone to stop a prescription. She did not stop hers. Coming off a drug that is doing a job you need done, without the person who prescribed it, trades one problem for a worse one.

What she is saying is smaller and harder to argue with: print the list. All of it. Take it to the person who prescribed most of it. Ask what it is doing downstream that nobody is watching.

“You are not asking them to justify themselves,” she said. “You are asking them to look at the whole page. It takes nine minutes.”

Her mother died not knowing her name, with a chart that recorded twenty-two years of excellent continence.

“No one will ever grasp what it is to watch someone disappear one memory at a time while everybody around you keeps telling you the numbers look good.” — Margaret Bowen’s daughter

She keeps the printed list in her bag.

“I take it to everything now,” she said. “Every appointment, every specialist. It is one page. It costs nothing.”

Her own dose came down. Her leaks did not come back.

Eighteen months on, she says the thing she notices most is not her hair.

Still on the list, but reading it

She has her mother’s handwriting on a card in a drawer, from the last year Margaret managed to send them.

“I am not angry at a tablet,” she said. “I am angry that in twenty-two years nobody put the page in front of her.”

“It is not beyond skin deep,” she said. “It is the whole of who somebody is.”

She now takes pumpkin seed oil daily and reviews her medication list every year.

“My hair is the least of what I got back,” she said.

Beyond the pill

Research into the anticholinergic-dementia association continues, and the studies to date establish association rather than cause. What is not in dispute is that the drug class blocks a chemical the brain uses to form memories, and that most people taking it have never been told so.

While bladder medications can be appropriate when prescribed and reviewed, brands like Biolgical offer a food-source option aimed at the hormone shift underneath the symptom. Everly Pumpkin Seed Oil is a cold-pressed softgel for women through midlife.

In two published trials, pumpkin seed oil measured roughly 40% more hair count over 24 weeks, and improved bladder symptom scores at six and twelve weeks.

“It is aimed at the thing underneath,” she said. “Not at the symptom on top of it.”